Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protara Therapeutics (TARA) Goodwill (2020 - 2022)

Protara Therapeutics' Goodwill history spans 3 years, with the latest figure at $29.5 million for Q3 2022.

  • Quarterly Goodwill changed 0.0% to $29.5 million in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $29.5 million through Sep 2022, changed 0.0% year-over-year, with the annual reading at $29.5 million for FY2021, 0.0% changed from the prior year.
  • Goodwill came in at $29.5 million for Q3 2022, roughly flat from $29.5 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $29.5 million in Q4 2020 to a low of $29.4 million in Q1 2020.
  • The 3-year median for Goodwill is $29.5 million (2020), against an average of $29.5 million.
  • The largest YoY upside for Goodwill was 0.51% in 2021 against a maximum downside of 0.0% in 2021.
  • Protara Therapeutics' Goodwill stood at $29.5 million in 2020, then changed by 0.0% to $29.5 million in 2021, then changed by 0.0% to $29.5 million in 2022.
  • Per Business Quant, the three most recent readings for TARA's Goodwill are $29.5 million (Q3 2022), $29.5 million (Q2 2022), and $29.5 million (Q1 2022).